Eda Dokumacıoğlu
Impact in
- Biochemistry top 10%
- Phytochemicals and Antioxidant Activities
- Antioxidant Activity and Oxidative Stress
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Liver Disease Diagnosis and Treatment 6
-
- Chemotherapy-induced organ toxicity mitigation 3
- Co-authors
- Hatice İskender (22 shared papers)Sinan Saral (7 shared papers)Tuğba Mazlum Şen (4 shared papers)Yalçın Kanbay (3 shared papers)İmran İnce (2 shared papers)A. Hayırlı (10 shared papers)Özgür Kaynar (3 shared papers)Adem Kaya (3 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (3 papers)European Cytokine Network (2 papers)Andrologia (1 paper)Diabetes & Metabolic Syndrome Clinical Research & Reviews (1 paper)Archives of Physiology and Biochemistry (1 paper)
- Partner nations
- TürkiyeUnited States
In The Last Decade
Eda Dokumacıoğlu
33 papers receiving 521 citations
Peers
Comparison fields: 5 of 89
- Biochemistry 76
- Geriatrics and Gerontology 26
- Pharmacology 52
- Drug Discovery 1
- Endocrinology, Diabetes and Metabolism 86
Countries citing papers authored by Eda Dokumacıoğlu
This map shows the geographic impact of Eda Dokumacıoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eda Dokumacıoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eda Dokumacıoğlu more than expected).
Fields of papers citing papers by Eda Dokumacıoğlu
This network shows the impact of papers produced by Eda Dokumacıoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eda Dokumacıoğlu. The network helps show where Eda Dokumacıoğlu may publish in the future.
Co-authors
The 25 scholars most cited alongside Eda Dokumacıoğlu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 144 | |
| 2 | 2017 | 44 | |
| 3 | 2016 | 43 | |
| 4 | 2018 | 42 | |
| 5 | 2018 | 31 | |
| 6 | 2018 | 28 | |
| 7 | 2021 | 23 | |
| 8 | 2019 | 21 | |
| 9 | 2018 | 20 | |
| 10 | 2018 | 16 | |
| 11 | 2020 | 14 | |
| 12 | 2016 | 11 | |
| 13 | 2021 | 11 | |
| 14 | 2018 | 11 | |
| 15 | 2021 | 10 | |
| 16 | 2017 | 10 | |
| 17 | 2024 | 8 | |
| 18 | 2021 | 7 | |
| 19 | 2019 | 6 | |
| 20 | 2023 | 5 |
About Eda Dokumacıoğlu
Eda Dokumacıoğlu is a scholar working on Epidemiology, Pathology and Forensic Medicine, Pharmacology, Endocrinology, Diabetes and Metabolism and Clinical Psychology, having authored 37 papers that have together received 531 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (6 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Diet, Metabolism, and Disease (4 papers), Phytochemicals and Antioxidant Activities (3 papers), Chemotherapy-induced organ toxicity mitigation (3 papers), Apelin-related biomedical research (2 papers), Eating Disorders and Behaviors (2 papers) and Adipose Tissue and Metabolism (2 papers). The work is most often cited by research in Biochemistry (76 citations), Geriatrics and Gerontology (26 citations), Pharmacology (52 citations), Drug Discovery (1 citation) and Endocrinology, Diabetes and Metabolism (86 citations). Eda Dokumacıoğlu has collaborated with scholars based in Türkiye and United States. Frequent co-authors include Hatice İskender, Sinan Saral, Tuğba Mazlum Şen, Yalçın Kanbay, İmran İnce, A. Hayırlı, Özgür Kaynar, Adem Kaya, Ahmet Musmul and Çiğdem Sevim. Their work appears in journals such as Biomedicine & Pharmacotherapy, European Cytokine Network, Andrologia, Diabetes & Metabolic Syndrome Clinical Research & Reviews and Archives of Physiology and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.